Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H25N5O8 |
| Molecular Weight | 499.4733 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC3=C1C=CC(=C3)C(=O)O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O
InChI
InChIKey=GQOGBHBGKZPIIP-ZFXLNCEJSA-N
InChI=1S/C23H25N5O8/c1-28-14-7-4-11(22(34)36-23-18(31)16(29)17(30)19(35-23)21(32)33)8-13(14)27-15(28)9-26-12-5-2-10(3-6-12)20(24)25/h2-8,16-19,23,26,29-31H,9H2,1H3,(H3,24,25)(H,32,33)/t16-,17-,18+,19-,23-/m0/s1
| Molecular Formula | C23H25N5O8 |
| Molecular Weight | 499.4733 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:10:08 GMT 2025
by
admin
on
Wed Apr 02 08:10:08 GMT 2025
|
| Record UNII |
B46PBR8M8E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
B46PBR8M8E
Created by
admin on Wed Apr 02 08:10:08 GMT 2025 , Edited by admin on Wed Apr 02 08:10:08 GMT 2025
|
PRIMARY | |||
|
1015167-36-8
Created by
admin on Wed Apr 02 08:10:08 GMT 2025 , Edited by admin on Wed Apr 02 08:10:08 GMT 2025
|
PRIMARY | |||
|
146675110
Created by
admin on Wed Apr 02 08:10:08 GMT 2025 , Edited by admin on Wed Apr 02 08:10:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
PLASMA; URINE
|
||
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
PLASMA; URINE
|
